Veterinary Medicines

RABORAL V-RG

Authorised
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Download as PDF

Product identification

Medicine name:
RABORAL V-RG
RABORAL V-RG
Active substance:
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
Target species:
  • Fox
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Vaccinia virus, expressing glycoprotein gene of rabies virus, Live
    100000000.00
    50% cell culture infectious dose
    /
    2.50
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07BD
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • Polystyrene box, packed in cardbox, containing 200 baits

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1260302 2/1995
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0018/001
Concerned member states:
  • Belgium
  • Luxembourg

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download